← Open Payments lookup

ELLIOT MYERS: Open Payments

NPI 1528481587 · CARENCRO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,799 in 83 payments from 16 companies in 2025. Trend: 2023 $499 · 2024 $681 · 2025 $1,799

Food & beverage: $1,682Education: $117
CompanyPaymentsAmount
Alkermes, Inc.12$276
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$262
Axsome Therapeutics, Inc.12$261
Vanda Pharmaceuticals Inc.8$188
E.R. Squibb & Sons, L.L.C.5$185
Teva Pharmaceuticals USA, Inc.5$159
ABBVIE INC.6$115
Supernus Pharmaceuticals, Inc.5$81
Neurocrine BioSciences, Inc.2$62
Otsuka America Pharmaceutical, Inc.3$62

Products named: ARISTADA, CAPLYTA, Auvelity, COBENFY, FANAPT, VRAYLAR, Qelbree, REXULTI.

Industry payments across LA — which companies pay providers there.